Cystadenocarcinoma
A malignant neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. The neoplastic cells manifest varying degrees of anaplasia and invasiveness, and local extension and metastases occur. Cystadenocarcinomas develop frequently in the ovaries, where pseudomucinous and serous types are recognized. (Stedman, 25th ed)
Cystadenocarcinoma, Mucinous
A malignant cystic or semisolid tumor most often occurring in the ovary. Rarely, one is solid. This tumor may develop from a mucinous cystadenoma, or it may be malignant at the onset. The cysts are lined with tall columnar epithelial cells; in others, the epithelium consists of many layers of cells that have lost normal structure entirely. In the more undifferentiated tumors, one may see sheets and nests of tumor cells that have very little resemblance to the parent structure. (Hughes, Obstetric-Gynecologic Terminology, 1972, p184)
Cystadenoma
Cystadenocarcinoma, Papillary
Cystadenocarcinoma, Serous
A malignant cystic or semicystic neoplasm. It often occurs in the ovary and usually bilaterally. The external surface is usually covered with papillary excrescences. Microscopically, the papillary patterns are predominantly epithelial overgrowths with differentiated and undifferentiated papillary serous cystadenocarcinoma cells. Psammoma bodies may be present. The tumor generally adheres to surrounding structures and produces ascites. (From Hughes, Obstetric-Gynecologic Terminology, 1972, p185)
Cystadenoma, Mucinous
Mucocele
Cysts
Pyonephrosis
Mixed Tumor, Mesodermal
Ovarian Neoplasms
Biliary Tract Neoplasms
Barium Sulfate
Pseudomyxoma Peritonei
A condition characterized by poorly-circumscribed gelatinous masses filled with malignant mucin-secreting cells. Forty-five percent of pseudomyxomas arise from the ovary, usually in a mucinous cystadenocarcinoma (CYSTADENOCARCINOMA, MUCINOUS), which has prognostic significance. Pseudomyxoma peritonei must be differentiated from mucinous spillage into the peritoneum by a benign mucocele of the appendix. (Segen, Dictionary of Modern Medicine, 1992)
Bile Ducts, Intrahepatic
Pancreatic Neoplasms
Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).
Tomography, X-Ray Computed
Pancreaticoduodenectomy
Encyclopedias as Topic
Judgment
Abdomen, Acute
Ferrets
Felis
Gingivectomy
Surgical excision of the gingiva at the level of its attachment, thus creating new marginal gingiva. This procedure is used to eliminate gingival or periodontal pockets or to provide an approach for extensive surgical interventions, and to gain access necessary to remove calculus within the pocket. (Dorland, 28th ed)
Apocrine Glands
Anal Sacs
Sarcoma, Alveolar Soft Part
A variety of rare sarcoma having a reticulated fibrous stroma enclosing groups of sarcoma cells, which resemble epithelial cells and are enclosed in alveoli walled with connective tissue. It is a rare tumor, usually occurring between 15 and 35 years of age. It appears in the muscles of the extremities in adults and most commonly in the head and neck regions of children. Though slow-growing, it commonly metastasizes to the lungs, brain, bones, and lymph nodes. (DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1365)
Mucin Hypersecreting Intraductal Papillary Neoplasm of the pancreas. (1/165)
Mucin Hypersecreting Intraductal Papillary Neoplasm is a rare neoplasm that arises from ductal epithelial cells. This entity is distinct from the more commonly known Mucinous Cystadenoma or Mucinous Cystadenocarcinoma. Despite this distinction, it has been erroneously categorized with these more common cystic neoplasms. Characteristic clinical presentation, radiographic, and endoscopic findings help distinguish this neoplasm from the cystadenomas and cystadenocarcinomas. Histopathologic identification is not crucial to the preoperative diagnosis. This neoplasm is considered to represent a premalignant condition and, therefore, surgical resection is warranted. Prognosis, following resection, is felt to be curative for the majority of patients. We present two cases of Mucin Hypersecreting Intraductal Papillary Neoplasm and discuss their diagnosis and surgical therapy. (+info)Cystadenomas and cystadenocarcinomas of the pancreas: a multiinstitutional retrospective study of 398 cases. French Surgical Association. (2/165)
OBJECTIVE: To review the features of patients with benign and malignant cystadenomas of the pancreas, focusing on preoperative diagnostic accuracy and long-term outcome, especially for nonoperated serous cystadenomas and resected cystadenocarcinomas. SUMMARY BACKGROUND DATA: Serous cystadenomas (SCAs) are benign tumors. Mucinous cystic neoplasms should be resected because of the risk of malignant progression. A correct preoperative diagnosis of tumor type is based on morphologic criteria. Despite the high quality of recent imaging procedures, the diagnosis frequently remains uncertain. Invasive investigations such as endosonography and diagnostic aspiration of cystic fluid may be helpful, but their assessment is limited to small series. The management of typical SCA may require resection or observation. Survival after pancreatic resection seems better for cystadenocarcinomas (MCACs) than for ductal adenocarcinomas of the pancreas. METHODS: Three hundred ninety-eight cases of cystadenomas of the pancreas were collected between 1984 and 1996 in 73 institutions of the French Surgical Association. Clinical presentation, radiologic evaluation, and surgical procedures were analyzed for 144 operated SCAs, 150 mucinous cystadenomas (MCAs), and 78 MCACs. The outcome of 372 operated patients and 26 nonoperated patients with SCA was analyzed. RESULTS: Cystadenomas represented 76% of all primary pancreatic cystic tumors (398/522). An asymptomatic tumor was discovered in 32% of patients with SCA, 26% of those with MCA, and 13% of those with MCAC. The tumor was located in the head or uncinate process of the pancreas in 38% of those with SCA, 27% of those with MCA, and 49% of those with MCAC. A communication between the cyst and pancreatic duct was discovered in 0.6% of those with SCA, 6% of those with MCA, and 10% of those with MCAC. The main investigations were ultrasonography and computed tomography (94% for SCA, MCA, and MCAC), endosonography (34%, 28%, and 22% for SCA, MCA, and MCAC respectively), endoscopic retrograde cholangiopancreatography (16%, 14%, 22%), and cyst fluid analysis (22%, 31%, 35%). An accurate preoperative diagnosis of tumor type was proposed for 20% of those with SCA (144 cases), 30% of those with MCA, and 29% of those with MCAC. An atypical unilocular macrocyst was observed in 10% of SCA cases. The most common misdiagnosis for mucinous cystic tumors was pseudocyst (9% of MCAs, 15% of MCACs). Intraoperative frozen sections (126 cases) allowed a diagnosis according to definitive histologic examination in 50% of those with SCA and MCA and 62% of those with MCAC. For management, 93% of patients underwent surgery. Nonoperated patients (7%) had exclusively typical SCA. A complete cyst excision was performed in 94% of benign cystadenomas, with an operative mortality rate of 2% for SCA and 1.4% for MCA. Resection was possible in 74% of cases of MCAC. Mean follow-up of 26 patients with nonresected SCAs was 38 months, and no patients required surgery. For resected MCACs, the actuarial 5-year survival rate was 63%. CONCLUSIONS: Spiral computed tomography is the examination of choice for a correct prediction of tumor type. Endosonography may be useful to detect the morphologic criteria of small tumors. Diagnostic aspiration of the cyst allows differentiation of the macrocystic form of SCA (10% of cases) and the unilocular type of mucinous cystic neoplasm from a pseudocyst. Surgical resection should be performed for symptomatic SCAs, all mucinous cystic neoplasms, and cystic tumors that are not clearly defined. Conservative management is wholly justified for a well-documented SCA with no symptoms. An extensive resection is warranted for MCAC because the 5-year survival rate may exceed 60%. (+info)Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS. (3/165)
Six human ovarian cancer cell lines and samples of ascites cells isolated from 27 patients with stage III or IV ovarian papillary serous cystadenocarcinoma were studied individually to test whether recombinant human Mullerian inhibiting substance (rhMIS) acts via its receptor. To do these experiments, we scaled up production of rhMIS and labeled it successfully with biotin for binding studies, cloned the human MIS type II receptor for mRNA detection, and raised antibodies to an extracellular domain peptide for protein detection. These probes were first tested on the human ovarian cancer cell lines and then applied to primary ovarian ascites cells. rhMIS inhibited colony growth of five of six cell lines that expressed the human MIS type II receptor mRNA by Northern analysis while not inhibiting receptor-negative COS cells. Flow cytometry performed on MIS-sensitive ovarian cancer cell lines demonstrated specific and saturable binding of rhMIS (Kd = 10.2 nM). Ascites cells from 15 of 27 or 56% of patients tested bound biotinylated MIS (MIS-biotin) and, of the 11 that grew in soft agarose, 9 of 11 or 82% showed statistically significant inhibition of colony formation. Of the 15 patients who bound biotinylated MIS, mRNA was available for analysis from 9, and 8 of 9 expressed MIS type II receptor mRNA by reverse transcription-PCR, showing a statistically significant correlation, compared with binding, by chi2 analysis (P = 0.025). Solid ovarian cancers were positive for the MIS type II receptor protein by immunohistochemical staining, which colocalized with staining for antibody to CA-125 (OC-125). Thus, the detection of the MIS type I receptor by flow cytometry may be a useful predictor of therapeutic response to MIS and may be a modality to rapidly choose patients with late-stage ovarian cancer for treatment with MIS. (+info)Mucobilia in association with a biliary cystadenocarcinoma of the caudate duct: a rare cause of malignant biliary obstruction. (4/165)
Mucobilia is a rare condition characterized by the accumulation of abundant mucus within the intra- or extrahepatic biliary tree. A variety of hepatobiliary and pancreatic neoplasms are mucin producing and have been associated with the development of mucobilia including biliary mucinosis, biliary papillomatosis, mucin-producing cholangiocarcinoma (MPCC), or cystic neoplasms of the pancreas or biliary tree (cystadenoma or cystadenocarcinoma). We report the case of 46 year-old male with a biliary cystadenocarcinoma of the caudate lobe which resulted in chronic biliary obstruction and relapsing cholangitis. A review of the literature for both mucobilia and biliary cystadenocarcinoma is provided along with a discussion addressing the clinical presentation, diagnosis, treatment, and prognosis for this rare entity. (+info)Fluorescent neoglycolipids. Improved probes for oligosaccharide ligand discovery. (5/165)
A second generation of lipid-linked oligosaccharide probes, fluorescent neoglycolipids, has been designed and synthesized for ligand discovery within highly complex mixtures of oligosaccharides. The aminolipid 1,2-dihexadecyl-sn-glycero-3-phosphoethanolamine (DHPE), which has been used extensively to generate neoglycolipids for biological and structural studies, has been modified to incorporate a fluorescent label, anthracene. This new lipid reagent, N-aminoacetyl-N-(9-anthracenylmethyl)-1, 2-dihexadecyl-sn-glycero-3-phosphoethanolamine (ADHP), synthesized from anthracenaldehyde and DHPE gives an intense fluorescence under UV light. Fluorescent neoglycolipids derived from a variety of neutral and acidic oligosaccharides by conjugation to ADHP, by reductive amination, can be detected and quantified by spectrophotometry and scanning densitometry, and resolved by TLC and HPLC with subpicomole detection. Antigenicities of the ADHP-neoglycolipids are well retained, and picomole levels can be detected using monoclonal carbohydrate sequence-specific antibodies. Among O-glycans from an ovarian cystadenoma mucin, isomeric oligosaccharide sequences, sialyl-Lea- and sialyl-Lex-active, could be resolved by HPLC as fluorescent neoglycolipids, and sequenced by liquid secondary-ion mass spectrometry. Thus the neoglycolipid technology now uniquely combines high sensitivity of immuno-detection with a comparable sensitivity of chemical detection. Principles are thus established for a streamlined technology whereby an oligosaccharide population is carried through ligand detection and ligand isolation steps, and sequence determination by mass spectrometry, enzymatic sequencing and other state-of-the-art technologies for carbohydrate analysis. (+info)Regulation of UT-OC-3 ovarian carcinoma cells by cytokines: inhibitory effects on cell proliferation and activation of transcription factors AP-1 and NF-kappaB. (6/165)
The present study was designed to investigate the growth regulatory effects of cytokines in UT-OC-3 ovarian cystadenocarcinoma cells in vitro. The effects of interleukin-6 (IL-6), interferons alpha (IFN-alpha) and gamma (IFN-gamma), granulocyte-macrophage colony-stimulating factor (GM-CSF), tumour necrosis factor alpha (TNF-alpha), and transforming growth factor beta1 (TGF-beta1) were investigated by (125)I-deoxyuridine ((125)IUdR) incorporation assay. In order to understand better the molecular mechanisms of the observed effects, the activation of DNA-binding proteins was studied by electrophoretic mobility shift assay. In addition, cellular DNA was tested by fragmentation analysis to determine if the most growth inhibitory cytokines are able to induce programmed cell death (apoptosis). After 48h in culture, TGF-beta1, TNF-alpha, IFN-alpha and IL-6 showed a clear inhibitory effect on (125)IUdR incorporation (P<0.005), and IFN-gamma and GM-CSF caused even more significant inhibition (P<0.001). IFN-alpha and IFN-gamma were both growth inhibitory after 72h in culture (P<0.005). Similarly, GM-CSF induced a slight inhibition (P<0.05), whereas TGF-beta1 and TNF-alpha almost blocked DNA synthesis (P<0.001) after 72h. IL-6 had no statistically significant effect on cell proliferation after 72h. Transcription factors AP-1 and NF-kappaB were both constitutively expressed in UT-OC-3 cells. The binding activity of AP-1 was found to be stimulated by the growth inhibitory cytokines, TGF-beta1 and TNF-alpha, and the binding of NF-kappaB was stimulated by TNF-alpha. Apoptosis does not seem to be induced by any of these cytokines in the UT-OC-3 ovarian cancer cell model. (+info)Genetic mapping of a naturally occurring hereditary renal cancer syndrome in dogs. (7/165)
Canine hereditary multifocal renal cystadenocarcinoma and nodular dermatofibrosis (RCND) is a rare, naturally occurring inherited cancer syndrome observed in dogs. Genetic linkage analysis of an RCND-informative pedigree has identified a linkage group flanking RCND (CHP14-C05.377-C05.414-FH2383-C05. 771-[RCND-CPH18]-C02608-GLUT4-TP53-ZuBe Ca6-AHT141-FH2140-FH2594) thus localizing the disease to a small region of canine chromosome 5. The closest marker, C02608, is linked to RCND with a recombination fraction (theta) of 0.016, supported by a logarithm of odds score of 16.7. C02608 and the adjacent linked markers map to a region of the canine genome corresponding to portions of human chromosomes 1p and 17p. A combination of linkage analysis and direct sequencing eliminate several likely candidate genes, including tuberous sclerosis 1 and 2 genes (TSC1 and TSC2) and the tumor suppressor gene TP53. These data suggest that RCND may be caused by a previously unidentified tumor suppressor gene and highlight the potential for canine genetics in the study of human disease predisposition. (+info)Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer. (8/165)
We previously demonstrated that AKT2, a member of protein kinase B family, is activated by a number of growth factors via Ras and PI 3-kinase signaling pathways. Here, we report the frequent activation of AKT2 in human primary ovarian cancer and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase (PI 3-kinase)/Akt pathway. In vitro AKT2 kinase assay analyses in 91 ovarian cancer specimens revealed elevated levels of AKT2 activity (>3-fold) in 33 cases (36.3%). The majority of tumors displaying activated AKT2 were high grade and stages III and IV. Immunostaining and Western blot analyses using a phospho-ser-473 Akt antibody that detects the activated form of AKT2 (AKT2 phosphorylated at serine-474) confirmed the frequent activation of AKT2 in ovarian cancer specimens. Phosphorylated AKT2 in tumor specimens localized to the cell membrane and cytoplasm but not the nucleus. To address the mechanism of AKT2 activation, we measured in vitro PI 3-kinase activity in 43 ovarian cancer specimens, including the 33 cases displaying elevated AKT2 activation. High levels of PI 3-kinase activity were observed in 20 cases, 15 of which also exhibited AKT2 activation. The remaining five cases displayed elevated AKT1 activation. Among the cases with elevated AKT2, but not PI 3-kinase activity (18 cases), three showed down-regulation of PTEN protein expression. Inhibition of PI 3-kinase/AKT2 by wortmannin or LY294002 induces apoptosis in ovarian cancer cells exhibiting activation of the PI 3-kinase/AKT2 pathway. These findings demonstrate for the first time that activation of AKT2 is a common occurrence in human ovarian cancer and that PI 3-kinase/Akt pathway may be an important target for ovarian cancer intervention. (+info)
Cystadenocarcinoma - Wikipedia
Cystadenocarcinoma Symptoms, Causes, Ultrasound, Treatment - Health Care Tips and Natural Remedies
salivary low-grade cribriform adenocarcinoma - Humpath.com - Human pathology
EDUCATION AND IMAGING. Hepatobiliary and Pancreatic: Long-term survival of serous cystadenocarcinoma of the pancreas with...
LPAR1 regulates the development of intratumoral heterogeneity in ovarian serous cystadenocarcinoma by activating the PI3K/AKT...
Intrahepatic cystadenocarcinoma with pleural dissemination: a case report. - Semantic Scholar
endometrial carcinoma mucinous drug therapy 2000:2010[pubdate] *count=100 - BioMedLib™ search engine
Cystadenocarcinoma | CTD
Familial association of specific histologic types of ovarian malignancy with other malignancies - Bermejo - 2004 - Cancer -...
Oral cavity - Cystadenocarcinoma
Primary malignant pericardial tumour in Lynch syndrome | BMC Cancer | Full Text
Reproductive factors and risk of ovarian cancer: a prospective study. - Clinical Trial Service Unit & Epidemiological Studies...
SurgPath4U Case Viewer
What are the clinical findings of neoplastic cysts of the liver?
Mucinous cystadenocarcinoma - Wikipedia
An extremely rare cause of acute abdomen in pregnancy: ruptured pancreatic mucinous cystadenocarcinoma.
Clinical Evidence for Adenoma-Carcinoma Sequence in Primary Retroperitoneal Mucinous Cystadenocarcinoma
Mucinous cystadenoma and cystadenocarcinoma - Herb Kosten Foundation
benign mesothelioma of peritoneum 2005:2010[pubdate] *count=100 - BioMedLib™ search engine
The long-term survival in primary retroperitoneal mucinous cystadenocarcinoma: a case report | Surgical Case Reports | Full Text
Plus it
A Copy Number Variant at the Locus Likely Confers Risk for Canine Squamous Cell Carcinoma of the Digit | proLékárníky.cz
sg:pub.10.1038/ng.3573 - Springer Nature SciGraph
Metastatic, papillary cystadenocarcinoma of the mammary gland in a black-footed ferret
Intra and extra-hepatic cystadenoma of the biliary duct. Review of literature and radiological and pathological characteristics...
Cystic pancreatic tumors] | Read by QxMD
Cystic pancreatic lesions: Current evidence for diagnosis and treatment.
Go to Characterization of Black Pigmenturia in a Cat with Apocrine Gland Cystadenocarcinoma.
Prestren | Bile duct cancer - Prestren
Ovarian serous cystadenofibroma | Radiology Case | Radiopaedia.org
CA54/61 as a Marker for Epithelial Ovarian Cancer<...
Extrahepatic biliary cystadenoma with mesenchymal stroma: a true biliary cystadenoma? A case report.
rs121913274 - SNPedia
rs121912656 - SNPedia
BioModels Database (Caltech mirror)
BioModels Database (Caltech mirror)
Biliary cystadenoma | Radiology Reference Article | Radiopaedia.org
Online Pharmacy: Cialis 5 mg opiniones brand pills!
Hepatic Cystadenomas: Background, Pathophysiology, Etiology
Cancer Antigen (CA) 27.29 - US Bio-Chem Medical Services
Carbohydrate Antigen (CA) 19-9 | LabCorp - Find Lab Tests Online
Vesalius Clinical Folios: Mucinous Cystadenoma of the Appendix
Most recent papers with the keyword Uterine serous cancer | Read by QxMD
Cancer Cell Metabolism Database ~~ Bioinformatics and Systems Medicine Laboratory ~~
Cancer Cell Metabolism Database ~~ Bioinformatics and Systems Medicine Laboratory ~~
Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International...
Definitions
Carbohydrate Antigen (CA) 19-9 Blood Test
JoVE Search Results: Cystadenomas%2C Papillary
Antigen CA 19.9 - Medical Daily News - Health News
Ovarian serous cystadenoma
"Ovarian serous cystadenocarcinoma , Radiology Reference Article , Radiopaedia.org". Radiopaedia. Retrieved 2019-09-21. v t e v ...
Cystadenoma
When malignant, it is called cystadenocarcinoma. When not otherwise specified, the ICD-O coding is 8440/0. However, the ... ISBN 978-1-4160-2999-1. Serous cystadenoma of pancreas at eMedicine Biliary cystadenoma/cystadenocarcinoma at eMedicine v t e. ...
Ovarian cancer
It includes serous tumor, endometrioid tumor, and mucinous cystadenocarcinoma. Less common tumors are malignant Endometrioid ... Mucinous tumors include mucinous adenocarcinoma and mucinous cystadenocarcinoma. Mucinous adenocarcinomas make up 5-10% of ...
Fibroblast growth factor receptor 1
... of ovarian Papillary serous cystadenocarcinoma (almost all amplifications); ~5% of colorectal cancers (~60 amplifications, 40% ...
Gestonorone caproate
https://www.popline.org/node/479231 Guthrie D (July 1979). "The treatment of advanced cystadenocarcinoma of the ovary with ...
Mucinous cystadenoma
Biliary cystadenoma and cystadenocarcinoma constitute less than 5% of intrahepatic cysts originating from the bile duct. ...
Liver cancer
Cancer of the bile duct (cholangiocarcinoma and cholangiocellular cystadenocarcinoma) account for approximately 6% of primary ...
Pancreatic serous cystadenoma
... "serous cystadenocarcinoma".[citation needed] These lesions rarely require surgery unless they are symptomatic or the diagnosis ...
Psammoma body
Ovarian papillary serous cystadenocarcinoma at WebPath, The Internet Pathology Laboratory for Medical Education at Mercer ... Papillary thyroid carcinoma Papillary renal cell carcinoma Ovarian papillary serous cystadenoma and cystadenocarcinoma ...
Folliculin
December 2003). "A mutation in the canine BHD gene is associated with hereditary multifocal renal cystadenocarcinoma and ...
International Classification of Diseases for Oncology
M8470/2 Mucinous cystadenocarcinoma, non-invasive (C25._) M8470/3 Mucinous cystadenocarcinoma/ NOS (C56.9) Pseudomucinous ... NOS M8471/3 papillary mucinous cystadenocarcinoma (C56.9) Papillary pseudomucinous cystadenocarcinoma M8472/1 Mucinous cystic ... NOS M8440/3 Cystadenocarcinoma, NOS M8441/0 Serous cystadenoma, NOS Serous cystoma Serous microcystic adenoma M8441/3 Serous ... M8161/3 Bile duct cystadenocarcinoma (C22.1, C24.0) M8162/3 Klatskin tumor (C22.1, C24.0) M8170/0 Liver cell adenoma (C22.0) ( ...
SK-OV-3
... ovarian cancer cell line derived from the ascites of a 64-year-old Caucasian female with an ovarian serous cystadenocarcinoma. ...
Leukotriene B4 receptor 2
... the Serous cystadenocarcinoma type of ovarian cancer, and uterine cervical carcinoma. Other studies have implicated BLT2 in ...
Estrogen receptor beta
... ovarian serous cystadenocarcinoma and ovarian cancer cell lines: down-regulation of ER-beta in neoplastic tissues". The Journal ...
Pseudomyxoma peritonei
... and mucinous cystadenocarcinoma), as well as other disease states. Other primary sites that have been reported include colon, ...
List of MeSH codes (C04)
... cystadenocarcinoma, mucinous MeSH C04.557.470.200.025.480.230 - cystadenocarcinoma, papillary MeSH C04.557.470.200.025.480.240 ... cystadenocarcinoma, papillary MeSH C04.557.470.590.480.240 - cystadenocarcinoma, serous MeSH C04.557.470.590.485 - cystadenoma ... cystadenocarcinoma MeSH C04.557.470.590.480.225 - cystadenocarcinoma, mucinous MeSH C04.557.470.590.480.230 - ... cystadenocarcinoma, serous MeSH C04.557.470.200.025.540 - klatskin's tumor MeSH C04.557.470.200.025.660 - paget's disease, ...
Salivary gland tumour
... adenocarcinoma Sebaceous carcinoma Sebaceous lymphadenocarcinoma Cystadenocarcinoma Low-grade cribriform cystadenocarcinoma ...
Surface epithelial-stromal tumor
75% are benign or of borderline malignancy, and 25% are malignant The malignant form of this tumor, serous cystadenocarcinoma, ...
Pancreatectomy
Cystadenocarcinoma Islet cell tumors (neuroendocrine tumors) Papillary cystic neoplasms Lymphoma Acinar cell tumors Severe ...
International Cancer Genome Consortium
... ovarian serous cystadenocarcinoma, lung squamous cell carcinoma, adrenocortical carcinoma, Diffuse Large B-cell lymphoma, ... Serous cystadenocarcinoma Canada: Pancreatic cancer - Ductal adenocarcinoma and prostate cancer - adenocarcinoma China: Gastric ...
Birt-Hogg-Dubé syndrome
... multifocal renal cystadenocarcinoma) and skin tumors (nodular dermatofibrosis). They had a similar pattern of tumorigenesis to ...
Testicular cancer
... borderline malignancy Serous carcinoma Well differentiated endometrioid tumor Mucinous cystadenoma Mucinous cystadenocarcinoma ...
Cyst
Simple cysts Hydatid cysts Biliary cystadenoma Biliary cystadenocarcinoma Polycystic liver disease Adrenal cyst: Types of ...
Cystic lesions of the pancreas
Pancreatic mucinous cystadenoma Pancreatic mucinous cystadenocarcinoma Parra-Herran, C. E.; Garcia, M. T.; Herrera, L; Bejarano ... Pancreatic serous cystadenoma Pancreatic serous cystadenocarcinoma Pancreatic mucinous cystic tumors (13.4%) ...
Cystadenocarcinoma
Bilateral presentation is common with serous cystadenocarcinoma. Papillary serous cystadenocarcinoma Ovarian serous cystadenoma ... Cystadenocarcinoma is a malignant form of a cystadenoma and is a cancer derived from glandular epithelium, in which cystic ... A cystadenocarcinoma contains complex multi-loculated cyst but with exuberant solid areas in places. It usually presents with ... King JC, Ng TT, White SC, Cortina G, Reber HA, Hines OJ (October 2009). "Pancreatic serous cystadenocarcinoma: a case report ...
Serous cystadenocarcinoma
... is a type of tumor in the cystadenocarcinoma grouping. Most commonly, the primary site of serous ... August 2005). "Serous cystadenocarcinoma of the pancreas: management of a rare entity". Pancreas. 31 (2): 182-7. doi:10.1097/01 ... 13(10):1864-8 (October 2009). "Pancreatic serous cystadenocarcinoma: a case report and review of the literature". Cite journal ... cystadenocarcinoma is the ovary. Rare occurrence in the pancreas has been reported, although this is not typical, with the ...
Mucinous cystadenocarcinoma
... is a type of tumor in the cystadenocarcinoma grouping. It can occur in the breast as well as in the ... Honma N, Sakamoto G, Ikenaga M, Kuroiwa K, Younes M, Takubo K (August 2003). "Mucinous cystadenocarcinoma of the breast: a case ... radiopaedia.org/articles/mucinous-cystadenocarcinoma-of-ovary v t e. ...
Papillary serous cystadenocarcinoma
Ovarian papillary serous cystadenocarcinoma at WebPath, The Internet Pathology Laboratory for Medical Education at Mercer ...
Mucinous cystadenocarcinoma of the lung
... (MCACL) is a very rare malignant mucus-producing neoplasm arising from the uncontrolled ... Butnor KJ, Sporn TA, Dodd LG (2001). "Fine needle aspiration cytology of mucinous cystadenocarcinoma of the lung: report of a ... Ishibashi H; Moriya T; Matsuda Y (November 2003). "Pulmonary mucinous cystadenocarcinoma: report of a case and review of the ... Gaeta M, Blandino A, Scribano E, Ascenti G, Minutoli F, Pandolfo I (1999). "Mucinous cystadenocarcinoma of the lung: CT- ...
Cystadenocarcinoma - Wikipedia
Cystadenocarcinoma is a malignant form of a cystadenoma and is a malignant neoplasm derived from glandular epithelium, in which ... Papillary serous cystadenocarcinoma "Female Genital Pathology". Retrieved 2009-03-23. King JC, Ng TT, White SC, Cortina G, ... Reber HA, Hines OJ (October 2009). "Pancreatic serous cystadenocarcinoma: a case report and review of the literature". J ...
Serous cystadenocarcinoma - Wikipedia
Serous cystadenocarcinoma is a type of tumor in the cystadenocarcinoma grouping. Most commonly, the primary site of serous ... August 2005). "Serous cystadenocarcinoma of the pancreas: management of a rare entity". Pancreas. 31 (2): 182-7. doi:10.1097/01 ... 13(10):1864-8 (October 2009). "Pancreatic serous cystadenocarcinoma: a case report and review of the literature". Cite journal ... cystadenocarcinoma is the ovary. Rare occurrence in the pancreas has been reported, although this is not typical, with the ...
Mucinous Cystadenocarcinoma, Appendix | SpringerLink
However, the distinction between a cystic carcinoma (i.e., cystadenocarcinoma) and one that is not cystic has not been shown to ... The term "mucinous cystadenocarcinoma" may be used for well-differentiated mucinous adenocarcinomas with cystic structures. ... Svrcek M. (2017) Mucinous Cystadenocarcinoma, Appendix. In: Carneiro F., Chaves P., Ensari A. (eds) Pathology of the ...
Biliary Cystadenoma/Cystadenocarcinoma Imaging: Overview, Radiography, Computed Tomography
encoded search term (Biliary Cystadenoma/Cystadenocarcinoma Imaging) and Biliary Cystadenoma/Cystadenocarcinoma Imaging What to ... Biliary Cystadenoma/Cystadenocarcinoma Imaging. Updated: Nov 28, 2015 * Author: Mohammad Alobaidi, MD; Chief Editor: John ... Biliary cystadenoma and cystadenocarcinoma: CT and sonographic findings. AJR Am J Roentgenol. 1989 Sep. 153(3):507-11. [Medline ... Koroglu M, Akhan O, Akpinar E, Oto A, Gumus B. Biliary cystadenoma and cystadenocarcinoma: two rare cystic liver lesions. JBR- ...
papillary cystadenocarcinoma
serous cystadenocarcinoma*adenocarcinoma*cystadenocarcinoma*survival rate*ovarian neoplasms*neoplasm staging*uterine neoplasms* ... Cystadenocarcinoma (papillary cystadenocarcinoma) of the salivary gland is a rare malignant neoplasm... ... Cystadenocarcinoma (papillary cystadenocarcinoma) of the submandibular gland. A Harimaya. Department of Otolaryngology, Sapporo ... Cystadenocarcinoma (papillary cystadenocarcinoma) of the submandibular gland. A Harimaya. Department of Otolaryngology, Sapporo ...
Pathology Outlines - Cystadenocarcinoma
2005 WHO classification considered low grade salivary duct carcinoma to be a variant of cystadenocarcinoma, designated as low ... Also called papillary cystadenocarcinoma, mucus producing adenopapillary (nonepidermoid) carcinoma, malignant papillary ... Cite this page: Fernandez NC Cystadenocarcinoma. PathologyOutlines.com website. http://www.pathologyoutlines.com/topic/ ...
Gastric metastasis of ovarian serous cystadenocarcinoma | IMCRJ
Gastric metastasis from ovarian serous cystadenocarcinoma is extremely rare. Case presentation: We herein report one case of a ... Gastric metastasis of ovarian serous cystadenocarcinoma Shiqiang Yang Xintai Hospital Affiliated to Taishan Medical University ... Background: Gastric metastasis from ovarian serous cystadenocarcinoma is extremely rare.. Case presentation: We herein report ...
Search of: 'methodist hospital' | Recruiting, Not yet recruiting, Available Studies | 'Cystadenocarcinoma' | Houston - List...
methodist hospital , Cystadenocarcinoma , Houston (25 studies) * methodist hospital , Recruiting, Not yet recruiting, ... methodist hospital , Recruiting, Not yet recruiting, Available Studies , Cystadenocarcinoma , Houston. Need help? See RSS ... 5 Studies found for: methodist hospital , Recruiting, Not yet recruiting, Available Studies , Cystadenocarcinoma , Houston ... Recruiting, Not yet recruiting, Available Studies , Cystadenocarcinoma , Houston (5 studies) * ...
Renal Cystadenocarcinoma Arising from Ovarian Adenocarcinoma in a Three Year Old Doberman Bitch | IVIS
An extremely rare cause of acute abdomen in pregnancy: ruptured pancreatic mucinous cystadenocarcinoma.
To our knowledge, there have been 2 published cases of pancreatic mucinous cystadenocarcinoma (PMC) during pregnancy in the ... Pancreatic cystadenocarcinoma is an extremely rare neoplasm in pregnancy. ... Previous Document: Mucinous cystadenocarcinoma of the pancreas during pregnancy.. Next Document: Triterpenoids and rexinoids as ... Pancreatic cystadenocarcinoma is an extremely rare neoplasm in pregnancy. To our knowledge, there have been 2 published cases ...
Proliferative Brenner Tumor with Borderline Mucinous Cystadenocarcinoma of the Ovary in a 75-Year-Old Woman
Histopathological examination revealed proliferative Brenner ovarian tumor with borderline mucinous cystadenocarcinoma, and ... We report here an extremely rare case of proliferative Brenner tumor with borderline mucinous cystadenocarcinoma of the ovary, ... We report here an extremely rare case of proliferative Brenner tumor with borderline mucinous cystadenocarcinoma of the ovary, ... Proliferative Brenner Tumor with Borderline Mucinous Cystadenocarcinoma of the Ovary in a 75-Year-Old Woman ...
Metastatic, papillary cystadenocarcinoma of the mammary gland in a black-footed ferret
Biliary cystadenocarcinoma | Radiology Reference Article | Radiopaedia.org
Biliary cystadenocarcinoma: a case report disease]. J Radiol. 2005;86 (9 Pt 1): 1035-7. J Radiol (link) - Pubmed citation. ... Biliary cystadenocarcinoma of the liver: the need for complete resection. Eur. J. Cancer. 1998;34 (12): 1845-51. Eur. J. Cancer ... Biliary cystadenoma and cystadenocarcinoma: CT and sonographic findings. AJR Am J Roentgenol. 1989;153 (3): 507-11. AJR Am J ... Intrahepatic biliary cystadenocarcinoma: clinical analysis of 4 cases. HBPD INT. 2009;8 (1): 71-4. HBPD INT (link) - Pubmed ...
Atypical breast cyst: adenocarcinoma | Radiology Case | Radiopaedia.org
salivary low-grade cribriform cystadenocarcinoma - Humpath.com - Human pathology
Low-grade cribriform cystadenocarcinoma (LGCCC) is a rare tumor of (...) ... Low-grade cribriform cystadenocarcinoma of salivary glands Definition: ... cystadenocarcinoma polymorphous low-grade adenocarcinoma carcinoma ex pleomorphic adenoma mammary analogue secretory carcinoma ... Low-grade cribriform cystadenocarcinoma of salivary glands: report of two cases and review of the literature. Wang L, Liu Y, ...
Autophagy promotes malignant migration and invasion via miR‑224‑5p/BCL2 in pancreatic mucinous cystadenocarcinoma MCC1 cells
Invasive mucinous cystadenocarcinoma of the pancreas. Pancreatic body and tail. 4. Female. 62. Pancreatic mucinous cystic tumor ... Clinicopathological data of four cases of pancreatic mucinous cystadenocarcinoma.. Patient number. Sex. Age (years). ... Invasive mucinous cystadenocarcinoma of the pancreas. Pancreatic body and tail. 0/1. ... Autophagy promotes malignant migration and invasion via miR‑224‑5p/BCL2 in pancreatic mucinous cystadenocarcinoma MCC1 cells. * ...
Osteopathic Approach to the Diagnosis of Appendiceal Mucinous Cystadenocarcinoma Mimicking Primary Ovarian Malignant Neoplasm |...
Osteopathic Approach to the Diagnosis of Appendiceal Mucinous Cystadenocarcinoma Mimicking Primary Ovarian Malignant Neoplasm. ... Osteopathic Approach to the Diagnosis of Appendiceal Mucinous Cystadenocarcinoma Mimicking Primary Ovarian Malignant Neoplasm ... Osteopathic Approach to the Diagnosis of Appendiceal Mucinous Cystadenocarcinoma Mimicking Primary Ovarian Malignant Neoplasm ... All of the findings together were consistent with primary PMP from a mucinous cystadenocarcinoma, with the appendix as the ...
Mucinous cystadenoma and cystadenocarcinoma of the vermiform appendix with particular reference to mucocele and pseudomyxoma...
Mucinous cystadenoma and cystadenocarcinoma of the vermiform appendix with particular reference to mucocele and pseudomyxoma...
Mucinous cystadenoma and cystadenocarcinoma of the vermiform appendix with particular reference to mucocele and pseudomyxoma ... Mucinous cystadenoma and cystadenocarcinoma of the vermiform appendix with particular reference to mucocele and pseudomyxoma ... Two cases were of mucinous cystadenocarcinoma and one of these was diagnosed as `pseudomyxoma peritonei. `Pseudomyxoma ... peritonei is a misnomer and is caused by dissemination of a mucinous cystadenocarcinoma within the peritoneal cavity. The ...
Primary mucinous cystadenocarcinoma of the renal pelvis misdiagnosed as ureteropelvic junction stenosis with renal pelvis stone...
Primary mucinous cystadenocarcinoma of the renal pelvis misdiagnosed as ureteropelvic junction stenosis with renal pelvis stone ... Mucinous cystadenocarcinoma of the renal pelvis: a case report and clues to histogenesis. Bmj Case Reports 2009: -, 2009 ... Primary mucinous cystadenocarcinoma of renal pelvis: a case report. Cases Journal 2(): 9395-9395, 2010 ... Primary mucinous cystadenocarcinoma of the renal pelvis misdiagnosed as ureteropelvic junction stenosis with renal pelvis stone ...
Gene Set - cystadenocarcinoma
Go to Characterization of Black Pigmenturia in a Cat with Apocrine Gland Cystadenocarcinoma.
openarchives.gr | Mucinous cystadenocarcinoma of the pancreas - outcome following different modes of treatment
Acinar Cell Cystadenocarcinoma disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials
Articles related to Acinar Cell Cystadenocarcinoma:. #. Title. Authors. PMID. Year. 1. Acinar Cell Cystadenocarcinoma of the ... MalaCards integrated aliases for Acinar Cell Cystadenocarcinoma:. Name: Acinar Cell Cystadenocarcinoma 12 15 71 ... MalaCards organs/tissues related to Acinar Cell Cystadenocarcinoma:. 40 Lung, Pancreas, Breast, Thyroid, Bone, Thymus, Brain ... MalaCards based summary : Acinar Cell Cystadenocarcinoma, also known as pancreatic acinar cell cystadenocarcinoma, is related ...
Cytomorphologic features of papillary cystadenocarcinoma of the parotid. | Docphin
Cytomorphologic features of papillary cystadenocarcinoma of the parotid. , Diagnostic cytopathology , 6/1/2002 ... Cytomorphologic features of papillary cystadenocarcinoma of the parotid. Kusum Kapila Kusum Verma 6/1/2002 ... Kapila K, Verma K. Cytomorphologic features of papillary cystadenocarcinoma of the parotid. Diagn Cytopathol. 2002;26(6):392-7. ... The fine-needle aspiration cytology findings in four cases of recently classified cystadenocarcinoma of the parotid gland are ...
Cystadenocarcinoma | CTD
Bile Duct Cystadenocarcinoma disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials
MalaCards integrated aliases for Bile Duct Cystadenocarcinoma:. Name: Bile Duct Cystadenocarcinoma 12 15 74 ... MalaCards based summary : Bile Duct Cystadenocarcinoma, also known as biliary cystadenocarcinoma, is related to sclerosing ... MalaCards organs/tissues related to Bile Duct Cystadenocarcinoma:. 42 Liver, Breast, Testis, Lung, Ovary, Pancreas, Thymus ... cystadenocarcinoma 30.5. CEACAM5 KRT7 MUC1 4. polycystic liver disease 1 with or without kidney cysts 29.3. CALB2 CEACAM5 KRT20 ...
Chemotherapy Help - Forums and Discussions - MedHelp - Page 2
TumorOvaryPancreasNeoplasmAdenocarcinomaCystadenoma and cystadenocarcinomaBiliarySalivary glandsDiagnosisPathologyCystPrimary retroperitoneal mucinous cystadenocarcinomaPancreatic CystadenocarcinomaPeritonealAppendixBile ductAbdominal painSerous cystadenomaAppendicealMetastasisIntrahepaticLiverImmunohistochemicalHuman ovarianParotid glandBenignTumorsMetastasesInvasionAcinarEndometrioidClinicalCaseWorld Health OrganFindingsMucinous cystadenomaDiseaseRare
Tumor15
- Serous cystadenocarcinoma is a type of tumor in the cystadenocarcinoma grouping. (wikipedia.org)
- We report here an extremely rare case of proliferative Brenner tumor with borderline mucinous cystadenocarcinoma of the ovary, metastasizing to the pleura in a 75-year-old woman. (scirp.org)
- Histopathological examination revealed proliferative Brenner ovarian tumor with borderline mucinous cystadenocarcinoma, and immunohistochemical examinations for the tumors, even mucus-rich tumor cells were positive for CK 7 and negative for CK 20, suggesting the tumor arising from transitional cells, not from mucus-producing ovarian surface epithelial tumor cells. (scirp.org)
- Low-grade cribriform cystadenocarcinoma (LGCCC) is a rare tumor of salivary gland which exhibits clinically indolent behavior. (humpath.com)
- A total of 4 paired paraffin-embedded pancreatic mucinous cystadenocarcinoma samples and matched adjacent tissues were obtained retrospectively from the Department of Pathology, Changhai Hospital (Shanghai, China) ( Table I ). The distance between the tumor and the adjacent tissue sampling point site was 15 mm. (spandidos-publications.com)
- Even if a cystadenocarcinoma is found, the prognosis is quite good if the tumor can be surgically removed. (kostenfoundation.com)
- Central papillary cystadenocarcinoma of the jaw is an extremely rare tumor with only three previously reported cases in the English literature. (scitechnol.com)
- The patholologic report from incisional biopsy was a papillary cystic tumor with a differential diagnosis of cystadenoma versus cystadenocarcinoma . (scitechnol.com)
- Clinical case description of a papillary mucinous cystadenocarcinoma, extremely rare malignant tumor in the salivary gland and difficult to diagnose, in geriatric patient. (bvsalud.org)
- Adenoma-borderline tumor-carcinoma sequence, which was substantiated in the pathogenesis of ovarian mucinous carcinoma, could be extrapolated to that of primary retroperitoneal mucinous cystadenocarcinoma. (fortunejournals.com)
- Here, we present a case of primary retroperitoneal mucinous cystadenocarcinoma that could lend evidence for the presence of adenoma?borderline tumor?carcinoma sequence in primary retroperitoneal mucinous tumor. (fortunejournals.com)
- thus, the tumor resembled mucinous cystadenocarcinoma that occurs in the ovary, appendix, or pancreas. (fujita-hu.ac.jp)
- The tumor was completely resected with a subsequent histopathological diagnosis of primary retroperitoneal mucinous cystadenocarcinoma (PRMC). (springeropen.com)
- A 70-year-old woman with a cystadenocarcinoma with the invasion to the stomach as a submucosal tumor is presented. (nagasaki-u.ac.jp)
- The tumor in the stomach was diagnosed as submucosal prior to operation, but was revealed as an invasive tumor from a bile duct cystadenocarcinoma in a left lobe of the liver during surgery. (nagasaki-u.ac.jp)
Ovary1
- Most commonly, the primary site of serous cystadenocarcinoma is the ovary. (wikipedia.org)
Pancreas2
- Mucinous cystadenocarcinoma of the pancreas during pregnancy. (biomedsearch.com)
- Hepatobiliary and Pancreatic: Long-term survival of serous cystadenocarcinoma of the pancreas with synchronous liver metastases after aggressive surgical resection. (semanticscholar.org)
Neoplasm4
- Cystadenocarcinoma is a malignant form of a cystadenoma and is a malignant neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. (wikipedia.org)
- Cystadenocarcinoma ( papillary cystadenocarcinoma ) of the salivary gland is a rare malignant neoplasm. (labome.org)
- Pancreatic cystadenocarcinoma is an extremely rare neoplasm in pregnancy. (biomedsearch.com)
- Martingano D, Gurm H, Oliff A, Martingano FX, Aglialoro G. Osteopathic Approach to the Diagnosis of Appendiceal Mucinous Cystadenocarcinoma Mimicking Primary Ovarian Malignant Neoplasm. (jaoa.org)
Adenocarcinoma1
- An invasive adenocarcinoma of the accessory parotid gland: a rare example developing from a low-grade cribriform cystadenocarcinoma? (biomedcentral.com)
Cystadenoma and cystadenocarcinoma2
- Biliary cystadenoma and cystadenocarcinoma: CT and sonographic findings. (radiopaedia.org)
- Biliary cystadenoma and cystadenocarcinoma: clinical-imaging-pathologic correlations with emphasis on the importance of ovarian stroma. (radiopaedia.org)
Biliary12
- The malignant counterpart is biliary cystadenocarcinoma, which is believed to arise from the premalignant form. (medscape.com)
- MRI signal characteristics of biliary cystadenoma/cystadenocarcinoma are not specific for the disease. (medscape.com)
- Some biliary cystadenomas may rarely develop into a cystadenocarcinoma 9 . (radiopaedia.org)
- Imaging cannot reliably differentiate cystadenoma from cystadenocarcinoma, but the presence of septal nodularity may favor the diagnosis of biliary cystadenocarcinoma versus a biliary cystadenoma 3,7 . (radiopaedia.org)
- Intrahepatic biliary cystadenocarcinoma: clinical analysis of 4 cases. (radiopaedia.org)
- Biliary cystadenocarcinoma of the liver: the need for complete resection. (radiopaedia.org)
- Mucinous biliary cystadenocarcinoma containing gas bubbles secondary to duodenal invasion. (radiopaedia.org)
- 8. Souei mhiri M, Graiess tlili K, Yacoubi MT. [Biliary cystadenocarcinoma: a case report disease]. (radiopaedia.org)
- Bile Duct Cystadenocarcinoma, also known as biliary cystadenocarcinoma , is related to sclerosing hemangioma and cystadenoma , and has symptoms including abdominal pain and icterus . (malacards.org)
- Mucinous cystic neoplasms of the liver [ 1 ], formerly known as bile duct/biliary cystadenoma and biliary cystadenocarcinoma [ 2 ], represent an enigmatic entity, characterised by unknown origin and peculiar morphology including the presence of ovarian-type stroma. (intechopen.com)
- Biliary cystadenocarcinoma arising in a congenital cyst. (uptodate.com)
- The case of a biliary cystadenoma containing foci of cystadenocarcinoma is reported, along with the first electron microscopic description of this lesion. (uptodate.com)
Salivary glands3
- Low-grade cribriform cystadenocarcinoma of salivary glands: report of two cases and review of the literature. (humpath.com)
- Papillary cystadenocarcinoma, in turn, comprises an extremely rare lesion, accounting for 0.5% of all epithelial lesions affecting the salivary glands 2 and according to the second largest survey on cystadenocarcinomas described in the literature, the highest prevalence is also observed in the major salivary glands 3 . (bvsalud.org)
- Cystadenocarcinoma of the salivary glands with potential lymph node metastasis. (go.jp)
Diagnosis3
- Biopsy will also provide better examination of cyst masses and provide definite diagnosis of exact forms of cystadenocarcinoma. (healthcaretip.com)
- Such as in our case, the differential diagnosis between cystadenocarcinoma and benign lesion is difficult occasionally. (bvsalud.org)
- The histopathologic features coupled with the CK7 immunoreactivity led to a diagnosis of high grade ovarian papillary cystadenocarcinoma. (biomedcentral.com)
Pathology2
- The final pathology was intraosseous papillary cystadenocarcinoma. (scitechnol.com)
- Clinical features of central papillary cystadenocarcinoma of the mandible mimic an odontogenic lesion and metastatic bone disease, careful review of radiograph and pathology should be done. (scitechnol.com)
Cyst1
- A cystadenocarcinoma contains complex multi-loculated cyst but with exuberant solid areas in places. (wikipedia.org)
Primary retroperitoneal mucinous cystadenocarcinoma2
- Primary retroperitoneal mucinous cystadenocarcinoma could arise from the pre-existing benign mucinous cystadenoma. (fortunejournals.com)
- Primary retroperitoneal mucinous cystadenocarcinoma (PRMC) is extremely rare, and its biological behavior, pathogenesis, optimum treatments, and prognosis remain to be elucidated. (springeropen.com)
Pancreatic Cystadenocarcinoma1
- Diseases associated with GLRX include Pancreatic Cystadenocarcinoma and Alzheimer Disease . (genecards.org)
Peritoneal2
- Pseudomyxoma peritonei' is a misnomer and is caused by dissemination of a mucinous cystadenocarcinoma within the peritoneal cavity. (bmj.com)
- Patients suffering from peritoneal cystadenocarcinoma treated with cytoreductive surgery and platinum chemotherapy. (healthcaretip.com)
Appendix6
- Svrcek M. (2017) Mucinous Cystadenocarcinoma, Appendix. (springer.com)
- Objective Mucinous cystadenocarcinoma of appendix is certainly a uncommon entity. (conferencecallsworld.com)
- A case of mucinous cystadenocarcinoma of the appendix with abdominal wall abscess successfully treated by percutaneous drainage and systemic chemotherapy-a case report]. (elsevier.com)
- A 76-year-old woman was diagnosed of mucinous cystadenocarcinoma of the appendix. (elsevier.com)
- We report a rare case of the conservative therapy of mucinous cystadenocarcinoma of appendix with abdominal wall abscess. (elsevier.com)
- Fingerprint Dive into the research topics of '[A case of mucinous cystadenocarcinoma of the appendix with abdominal wall abscess successfully treated by percutaneous drainage and systemic chemotherapy-a case report]. (elsevier.com)
Bile duct2
- An important gene associated with Bile Duct Cystadenocarcinoma is KRT20 (Keratin 20), and among its related pathways/superpathways are O-linked glycosylation and Cytoskeletal Signaling . (malacards.org)
- Papillary cystadenocarcinoma ofextrahepatic left bile duct. (bvsalud.org)
Abdominal pain1
- Acinar Cell Cystadenocarcinoma, also known as pancreatic acinar cell cystadenocarcinoma , is related to cystadenocarcinoma and hypereosinophilic syndrome , and has symptoms including abdominal pain , pruritus and icterus . (malacards.org)
Serous cystadenoma1
- Amongst benign tumors, serous cystadenoma was the most frequent subtype, while for the malignant tumors serous cystadenocarcinoma was the commonest. (thefreelibrary.com)
Appendiceal1
- Summary The manifestation degrees of miRNAs examined were significantly modified in the appendiceal mucinous cystadenocarcinoma examples set alongside the mucinous cystadenoma. (conferencecallsworld.com)
Metastasis3
- Gastric metastasis from ovarian serous cystadenocarcinoma is extremely rare. (dovepress.com)
- In the present study, a case of isolated small intestine metastasis of ovarian papillary cystadenocarcinoma was reported. (biomedcentral.com)
- To the best of our knowledge, this is the first case of small intestine serousal surface metastasis from ovarian papillary cystadenocarcinoma. (biomedcentral.com)
Intrahepatic1
- Intrahepatic cystadenocarcinoma with pleural dissemination: a case report. (semanticscholar.org)
Liver1
- We report a case of serous cystadenocarcinoma with extensive local invasion and liver metastases. (biomedcentral.com)
Immunohistochemical1
- Immunohistochemical and ultrastructural findings in a rare case of papillary cystadenocarcinoma arising from the left sublingual gland of a 55-year-old Japanese man are reported. (labome.org)
Human ovarian1
- To explore the role of lysophosphatidic acid receptor 1 (LPAR1) and its correlation with the PI3K/AKT pathway in the development of intratumoral heterogeneity (ITH) in human ovarian serous cystadenocarcinoma (OSC). (biomedcentral.com)
Parotid gland2
- The fine-needle aspiration cytology findings in four cases of recently classified cystadenocarcinoma of the parotid gland are reported. (docphin.com)
- We report a case of cystadenocarcinoma occurring on the parotid gland of a 61-year-old female patient presenting palpable mass on her left cheek . (bvsalud.org)
Benign3
- Also called glycogen-rich cystadenoma or microcystic adenoma is generally considered to be a benign condition although serous cystadenocarcinoma is a rare but known malignant condition described in the literature. (biomedcentral.com)
- Most of these are benign (serous cystadenomas), and in rare cases are malignant (serous cystadenocarcinoma). (biomedcentral.com)
- CT scan must be done for benign serous tumors and first portion is done for diagnosing the stage after evaluation of cystadenocarcinoma. (healthcaretip.com)
Tumors2
- Mucoepidermoid carcinoma, salivary duct carcinoma, and cystadenocarcinoma are part of this group of mucin-producing tumors, among others. (bvsalud.org)
- Cystadenocarcinoma is classified as a low-grade histological subtype of salivary gland tumors. (go.jp)
Metastases1
- Long-term follow-up paying close attention to lymph node metastases is necessary for cystadenocarcinoma. (go.jp)
Invasion1
- During exploratory laparo- and thoracotomy, a hepatic cystadenocarcinoma with invasion of the diaphragm and pleural dissemination was discovered. (semanticscholar.org)
Acinar2
- An important gene associated with Acinar Cell Cystadenocarcinoma is SERPINA3 (Serpin Family A Member 3). (malacards.org)
- Ovarian cystadenocarcinoma is characterized by marked heterogeneity and may be composed of an admixture of histologic growth patterns, including acinar, papillary and solid. (biomedcentral.com)
Endometrioid1
- For younger women (ages 40-45 years) whose mothers were affected with endometrial malignancies, the risk of developing endometrioid carcinoma was slightly greater than the risk of developing papillary serous cystadenocarcinoma. (wiley.com)
Clinical2
- Despite the favorable clinical features, after surgical removal, was diagnosed as papillary mucinous papillary mucinous cystadenocarcinoma. (bvsalud.org)
- We discuss the clinical and histopathological features of cystadenocarcinoma with the review of the literature . (bvsalud.org)
Case1
- A case of primary mucinous cystadenocarcinoma of the lung is presented. (fujita-hu.ac.jp)
World Health Organ1
- It was first defined as papillary cystadenocarcinoma in the 1991 World Health Organization ( WHO ) classification , and it was reclassified as cystadenocarcinoma in the 2005 WHO classification . (bvsalud.org)
Findings1
- Laparoscopy is done for cystadenocarcinoma findings. (healthcaretip.com)
Mucinous cystadenoma4
- The quantitative RT-PCR validated how the manifestation of miR-1, was considerably down controlled in mucinous cystadenocarcinoma set alongside the mucinous cystadenoma (p 0.05). (conferencecallsworld.com)
- Statistical analysis The NVP-LDE225 biological activity non-parametric Mann-Whitney test was used to assess the differences in the miRNA expression level between the mucinous cystadenoma and mucinous cystadenocarcinoma samples using GraphPad StatMate software (GraphPad Software Inc.). The p values that represent differences between the two groups Hbg1 are displayed in the graph. (conferencecallsworld.com)
- Results Patients demographic and pathologic characteristics The study cohort included twelve cases of mucinous cystadenoma and six cases of mucinous cystadenocarcinoma. (conferencecallsworld.com)
- and were considerably down regulated generally in most of the examples of mucinous cystadenocarcinoma set alongside the mucinous cystadenoma (p 0.05) confirmed by real-time RT-PCR which is certainly demonstrated in Body 4. (conferencecallsworld.com)
Disease2
- 273 genes co-occuring with the disease cystadenocarcinoma in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. (mssm.edu)
- En bloc resection with adjuvant postoperative radiotherapy in high stage disease, and long-term follow-up allow the patient to have a favourable prognosis. (scitechnol.com)
Rare1
- An extremely rare cause of acute abdomen in pregnancy: ruptured pancreatic mucinous cystadenocarcinoma. (biomedsearch.com)